January 5, 2023
Watch a few of the ECOG-ACRIN cancer research advocates explain why cancer research is about more than just science
January 5, 2023
This study is for patients who have aggressive, high-grade tumors that put them at higher risk of recurrence after treatment
January 5, 2023
This trial is evaluating the effect of adding immune system therapy to the usual treatment (chemotherapy and radiation)
January 5, 2023
This trial is seeking to find out whether patients with the PD-L1 biomarker can either delay having chemotherapy or avoid it altogether
January 5, 2023
The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes
January 5, 2023
Adding immunotherapy to standard chemotherapy keeps most patients in remission and improves their survival